Journal article icon

Journal article

Complement biomarkers as predictors of disease progression in Alzheimer's disease.

Abstract:

There is a critical unmet need for reliable markers of disease and disease course in mild cognitive impairment (MCI) and early Alzheimer's disease (AD). The growing appreciation of the importance of inflammation in early AD has focused attention on inflammatory biomarkers in cerebrospinal fluid or plasma; however, non-specific inflammation markers have disappointed to date. We have adopted a targeted approach, centered on an inflammatory pathway already implicated in the disease. Complement, ...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.3233/JAD-160420

Authors


More from this funder
Name:
National Institute for Health Research
More from this funder
Name:
London and Maudsley NHS Foundation Trust
Publisher:
IOS Press
Journal:
Journal of Alzheimer's Disease More from this journal
Volume:
54
Issue:
2
Pages:
707-716
Publication date:
2016-09-01
Acceptance date:
2016-06-14
DOI:
EISSN:
1875-8908
ISSN:
1387-2877
Pmid:
27567854
Language:
English
Keywords:
Pubs id:
pubs:641618
UUID:
uuid:a6a19553-7d7f-4a25-b959-aabf599538da
Local pid:
pubs:641618
Source identifiers:
641618
Deposit date:
2017-07-18

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP